Many different healthcare centres exist in Europe engaged in the area of cardiovascular risk prevention, but with a wide range of quality of care. 1 An accreditation system is an efficient way to provide: (a) confidence to the patients and their caretakers that quality care is delivered according to professional standards; (b) centres with a tool to test their performance against other centres and to distinguish themselves in the cardiovascular prevention landscape. However, accreditation systems that assess the quality of care of centres providing cardiovascular care across Europe do not exist. The European Association of Preventive Cardiology (EAPC) of the European Society of Cardiology (ESC) has taken up the challenge of developing a preventive cardiology centre accreditation system. The accreditation system can be used as a tool to test performance and quality against benchmarks set by a trusted party and to enable the centre to receive recognition of the quality of infrastructure, equipment/facilities, staff and care. 2 
Arterial hypertension phenotypes and cardiovascular risk
Despite the fact that antihypertensive treatment is highly efficacious in improving outcomes, a significant proportion of on-treatment patients still have blood pressure levels not under control. 3 The high heterogeneity of hypertensive patients, in terms of cardiovascular outcomes and comorbidities as well as responses to antihypertensive pharmacotherapy, has been advocated as a potential cause. 4 In the present issue, an attempt has been performed to categorise patient subgroups accurately, optimise management strategies and forecast prognostic trajectories. Using a data-driven approach, hypertensive subjects enrolled in the SPRINT (Systolic Blood Pressure Intervention Trial) 5 were stratified into four phenotypically distinct subgroups with specific profiles on cardiovascular prognoses and responses to intensive antihypertensive treatment: group 1 (index hypertensives); group 2 (chronic kidney disease hypertensives); group 3 (obese hypertensives) and group 4 (extra risky hypertensives). The investigators should be congratulated on enriching our insight into the results and clinical interpretation of the SPRINT study that can expand our knowledge and ameliorate the proposed blood-pressure-lowering strategies. These results should be taken as hypothesis-generating and warrant further validation in future prospective studies.
Pregnancy hypertensive conditions affect child cardiometabolic health
Hypertensive disorders of pregnancy (HDPs) increase the risk of maternal cardiovascular disease later in life: there is an increased risk of future hypertension, ischaemic heart disease, stroke, venous thromboembolism and death from any cause. Moreover, these disorders have been associated with long-term consequences for the cardiovascular health of offspring. This is confirmed in the present issue by a systematic review where HDP was associated with higher blood pressure prevalence in childhood and adulthood (age range 3-19 years). However, no association was found between exposure to HDPs and levels of cholesterol, triglycerides or glucose. Taking into account all of the aforementioned adverse outcomes of children, HDPs create a population (mothers and their children) that has a composite increased cardiovascular risk profile from early life. This population may benefit from primary prevention strategies and a healthy lifestyle approach directed at the whole family after pregnancy. 6, 7 Obesity paradox in heart failure: still a matter of debate While intentional weight loss is known to improve haemodynamic function and cardiac structure in the general population, and obesity is an independent risk factor for cardiovascular disease development, 8 in heart failure patients the association of obesity and improved survival has been repeatedly observed. In the present issue, it is claimed that obesity defined by body mass index (BMI) or by percentage body fat (PBF), is characterised by better prognosis and lower plasma N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in heart failure patients, but not by a reduction in highsensitivity troponin T (hs-TnT) and soluble suppression of tumorigenesis-2 (sST2). In obese patients (BMI > 30 kg/m 2 , third PBF tertile), NT-proBNP did not predict the outcome, while hs-TnT and sST2 independently predicted the outcome. It is clear that the new data about hs-TnT and sST2 must be implemented in daily practice and it will be advantageous to take into account all three discussed biomarkers (NT-pro-BNP, hs-TnT, sST2) and control them in chronic heart failure (CHF) populations. More complete understanding of the obesity paradox and its difference in specific subgroups is needed. These results should then be verified in prospective studies using direct measurements of body composition or anthropometric measures, as in prior studies. 9 Further research is needed to generate evidence-based guidelines for weight management in established CHF.
Health literacy (HL) and patient-physician communication
HL refers to the knowledge, motivation and competencies to assess, understand, appraise and apply health-related information within healthcare, disease prevention and health-promoting settings. In fact. low HL is significantly associated with smoking, unhealthy food choices, less physical activity and low adherence to medication. 10 Thus, efforts to enhance HL are also highly relevant for cardiovascular disease prevention. However, studies on how to enhance HL in specific groups (e.g. ethnic minorities, higher age, male gender, low income and/or educational level) of patients at risk and with manifest cardiovascular disease are scarce. In this issue, a prospective cohort trial on the efficacy of a 'skills-based intervention' on knowledge of cardiovascular disease risk factors and symptoms (as important parts of HL) in 407 socially disadvantaged, middle-aged women in Jerusalem is presented. A HL intervention was designed through focus groups with women in low socioeconomic status communities. The intervention aimed to increase patient-physician communication skills through doctor visit preparation and better visit management, to improve perceived efficacy in patient-physician interaction and to expand cardiovascular disease knowledge. In conclusion, community-based group interventions seem to benefit and to increase HL in socially deprived women.
What are the cardiovascular effects of space radiation?
The effects of atmospheric radiation space exploration on cancer have been investigated, but little is known of their effect on the cardiovascular system. Here, the authors addressed the space environment and the longterm damage to the vascular endothelium by space radiation (protons and high Z and energy particles). The authors state that, based on National Aeronautics and Space Administration (NASA) estimations, each cell is crossed by a proton every three days while a helium nucleus and a heavy ion traverse each cell every few weeks and every few months, respectively. The effects on animal experiments as well on humans, in particular related to the effects on the heart with risk of heart failure, are reviewed. Finally, potential pharmacological countermeasures are discussed here.
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